[1]
“Exploring the Impact of 12-week Direct Acting Antiviral Therapy on Laboratory Parameters in HCV Patients: A Comparative Study”, mfm, vol. 35, no. 2, Mar. 2024, Accessed: May 31, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/45